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February 3, 2009:457–9Therefore, with the limitations of the National Hospital Dis-
harge Survey, we are unable to conclude that the increase in the
revalence of diastolic heart failure contributed to the finding of
ncreasing heart failure hospitalization over the past 25 years.
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levated N-Terminal Pro-B-Type
atriuretic Peptide Levels:
he Effect of Chronic
bstructive Pulmonary Disease
e read with great interest the recent article by Daniels et al. (1)
n which the investigators reported that detectable cardiac troponin
and N-terminal pro-B-type natriuretic peptide (NT-proBNP)
ere both associated with increased all-cause and cardiovascular
eath in healthy older adults.
NT-proBNP was previously identified as a prognostic cardiac
isk marker associated with increased mortality. NT-proBNP is
eleased by cardiac myocytes in response to wall stress in conditions
ssociated with volume overload as in heart failure and chronic
idney disease, pressure overload as in patients with heart valve
bnormalities, and ischemia owing to coronary disease. In the
resent study, the association remained even after participants with
aseline coronary heart disease were excluded, which was 30% of
he subjects with elevated (450 pg/ml) NT-proBNP levels.
However, the authors might have overlooked the effect of
hronic obstructive pulmonary disease (COPD) on NT-proBNP
evels. COPD is associated with cardiovascular disease and is an
ndependent risk factor for cardiovascular morbidity and mortality
2). We recently investigated the relationship between COPD,
oth the presence and severity, and NT-proBNP levels in 376
atients. To mitigate the influence of heart failure, chronic kidney
isease, and myocardial ischemia, we adjusted for history of angina
ectoris, myocardial infarction, heart failure, and renal function. In
ddition, all patients had resting left ventricular function of more
han 40% using echocardiography. The severity of COPD was assessed using pulmonary function tests with the GOLD (Global
nitiative for Chronic Obstructive Lung Disease) classification.
e found COPD to be an independent risk factor for increased
T-proBNP levels, and the levels increased with the severity of
OPD.
The underlying mechanism is likely to be pulmonary hyperten-
ion and right ventricular dysfunction caused by pulmonary arterial
ressure overload (3). COPD may induce wall stretching, ven-
ricular dilation, and/or increased vascular pressures, which may
romote the secretion of the neurohormone NT-proBNP.
ecause COPD is common in the elderly population (affecting
early 35% of this population) (4), the addition of spirometric data
o the analysis by Daniels et al. (1) would have been very
nteresting and informative. The less severe forms of COPD are
ften asymptomatic and therefore frequently underestimated, es-
ecially in the elderly. Thus, the presence of underlying COPD
ight have contributed to the observed correlation between
T-proBNP and outcome in this elderly population.
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e thank Dr. van Gestel and colleagues for their interest in our
ork (1). They wonder whether the presence of underlying chronic
bstructive pulmonary disease (COPD) might have contributed to
he strong association between N-terminal pro-B-type natriuretic
eptide (NT-proBNP) and outcomes in the Rancho Bernardo
tudy. We did not find this to be the case.
Dr. Van Gestel and colleagues stated that COPD affects nearly
5% of the elderly population; however, the article that they
eference actually found this incidence only in current smokers (2).
he cumulative incidence of COPD was only 14% in ex-smokers
nd 12% in never-smokers.
